PharmaRoth Labs, Inc. (ROTH)

[Jayyy]

An investigator who is a shareholder or who has a large financial interest (defined variously as more than $10 000 to more than $50 000) in the company sponsoring or otherwise involved in the trial has a clear conflict of interest and should either avoid direct participation in the study or disclose his or her financial involvement clearly to potential enrollees and to the appropriate Institutional Review Board (IRB).27

Financial or other pressures may tempt an investigator to falsify data, an illegal and unacceptable action. The investigator must hold himself or herself, along with the trial staff, to the highest ethical standards to maintain the integrity of the study. The investigator’s conduct must be able to withstand external scrutiny with respect to the scientific questions being addressed, the ethics of the intervention (and the control arm of the trial), and the financial aspects of the study.